RecruitingNCT05590715
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
International, Multicentric, Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
Sponsor
Stalicla SA
Enrollment
1,500 participants
Start Date
Oct 13, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication
Eligibility
Min Age: 12 YearsMax Age: 65 Years
Inclusion Criteria4
- Participants previously diagnosed with ASD (DSM-5)
- Available well-documented health records within the first 2 years of life
- Participants must have a parent or reliable caregiver who agrees to provide information about the participant
- Participants willing and consenting or assenting to participate.
Exclusion Criteria2
- Episode of fever (i.e. ≥100.5 °F or ≥ 38 °C) or clinically significant illness without fever (as judged by the investigator), within 10 days before any study assessment.
- If the investigator assesses any unwillingness or any medical condition that may prevent the subject from completing this study.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(21)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05590715
Related Trials
Promoting Emotional and Autonomic Control Through Guided Breathing Exercises for Emerging Adults With Autism
NCT072381532 locations
DINO RCT - Treating Anxiety in Children With Autism
NCT060669831 location
Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism
NCT040600302 locations
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
NCT043227342 locations
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
NCT065233871 location